News
OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste) in Australia for the treatment of skin cancer lesions and skin tumors
Garching n. Munich, Germany, (December 18th, 2020) – OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd. Australia a Medical Device…
OncoBeta GmbH and Australian Nuclear Science and Technology Organisation sign Letter of Intent to establish manufacturing site in Australia
Innovative medical device Rhenium-SCT therapy for Non-Melanoma Skin Cancer to be produced in Australia
Group RPH and OncoBeta GmbH sign agreement for Sales Referral and Distribution of Rhenium-SCT® in Brazil.
Grupo RPH is now the Official Rhenium-SCT® Sales Representative and Distributor in Brazil for the treatment of Non-Melanoma Skin Cancer.
Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study
Abstract Objectives This study aimed to provide long-term clinical data about an innovative epidermal radioisotope therapy called Rhenium-SCT® (Skin…
China Isotope & Radiation Corporation (CIRC) and OncoBeta sign distribution agreement for Tungsten 188/Rhenium-188 generators
Beijing, China and Garching near Munich, Germany, Tuesday 30th June 2020. CIRC and OncoBeta today announced that they have signed an agreement for the…
How can you Reduce the Risk of Skin Cancer?
Skin Cancer is the most common type of cancer in the world 1. Ultraviolet (UV) Radiation exposure is one of the major causes of melanoma and…
COVID-19: We are here for you.
To our Valued Patients, Customers and Health Care providers, As we navigate through these trying times surrounding the Coronavirus (COVID-19)…
B.J. Madan & Co India and OncoBeta announce exclusive distribution agreement for W/Re-188 generators.
New Delhi, India and Garching near Munich, Germany, 6th March, 2020. B.J Madan & Co and OncoBeta announced the execution of an exclusive distribution…
RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada.
RadioMedix and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the…
Oncobeta chosen as one of the Trailblazing Companies to Watch in 2019
OncoBeta- A Pioneer And Innovator In The Epidermal Radioisotope Therapy Sector Skin is the largest organ of the body and represents the first barrier…